EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) Disorders

Miles D Thompson iD, Alexej Knaus iD

Genes · 14.05.2024 · 15 (5) · 619

DOI: 10.3390/genes15050619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 14.05.2024. Verfasst von Miles D Thompson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Krembil Brain Institute, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. Hauptthemen laut MEDLINE: Congenital Disorders of Glycosylation, Developmental Disabilities, Glycosylphosphatidylinositols. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The case report by Mabry et al. (1970) of a family with four children with elevated tissue non-specific alkaline phosphatase, seizures and profound developmental disability, became the basis for phenotyping children with the features that became known as Mabry syndrome. Aside from improvements in the services available to patients and families, however, the diagnosis and treatment of this, and many other developmental disabilities, did not change significantly until the advent of massively parallel sequencing. As more patients with features of the Mabry syndrome were identified, exome and genome sequencing were used to identify the glycophosphatidylinositol (GPI) biosynthesis disorders (GPIBDs) as a group of congenital disorders of glycosylation (CDG). Biallelic variants of the phosphatidylinositol glycan (PIG) biosynthesis, type V (PIGV) gene identified in Mabry syndrome became evidence of the first in a phenotypic series that is numbered HPMRS1-6 in the order of discovery. HPMRS1 [MIM: 239300] is the phenotype resulting from inheritance of biallelic PIGV variants. Similarly, HPMRS2 (MIM 614749), HPMRS5 (MIM 616025) and HPMRS6 (MIM 616809) result from disruption of the PIGO, PIGW and PIGY genes expressed in the endoplasmic reticulum. By contrast, HPMRS3 (MIM 614207) and HPMRS4 (MIM 615716) result from disruption of post attachment to proteins PGAP2 (HPMRS3) and PGAP3 (HPMRS4). The GPI biosynthesis disorders (GPIBDs) are currently numbered GPIBD1-21. Working with Dr. Mabry, in 2020, we were able to use improved laboratory diagnostics to complete the molecular diagnosis of patients he had originally described in 1970. We identified biallelic variants of the PGAP2 gene in the first reported HPMRS patients. We discuss the longevity of the Mabry syndrome index patients in the context of the utility of pyridoxine treatment of seizures and evidence for putative glycolipid storage in patients with HPMRS3. From the perspective of the laboratory innovations made that enabled the identification of the HPMRS phenotype in Dr. Mabry’s patients, the need for treatment innovations that will benefit patients and families affected by developmental disabilities is clear.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital Disorders of GlycosylationDevelopmental DisabilitiesGlycosylphosphatidylinositolsFemaleHumansMaleMannosyltransferasesMembrane ProteinsMutationPhenotype

Stichwörter der Autor:innen

Mabry syndromecase studyglycophosphatidylinositol (GPI) biosynthesis disorder (GPIBD)human phenotype ontology (HPO) analysishyperphosphatasia with neurologic deficit (HPMRS)identity by descent filteringwhole exon sequencingwhole genome sequencing

Substanzen

GlycosylphosphatidylinositolsMannosyltransferasesMembrane ProteinsPIGV protein, human

Autor:innen und Institutionen

  • Krembil Brain Institute, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada.
  • Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.

ORCID-Profile: Miles D Thompson, Alexej Knaus

Zitieren

APA

Thompson, M. D., & Knaus, A. (2024). Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) Disorders. Genes, 15(5), 619. https://doi.org/10.3390/genes15050619

Vancouver

Thompson MD, Knaus A. Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) Disorders. Genes. 2024;15(5):619. doi:10.3390/genes15050619

BibTeX
@article{Thompson2024,
  author = {Thompson, Miles D and Knaus, Alexej},
  title = {Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) Disorders},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {5},
  pages = {619},
  doi = {10.3390/genes15050619}
}
Kostenlos starten →